# OnCo record thymoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/thymoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "thymoma" ;
  schema:name "Thymoma (WHO types A, AB, B1, B2 and B3)"@en ;
  schema:alternateName "Thymoma"@en, "Type A thymoma"@en, "Type AB thymoma"@en, "Type B thymoma"@en, "Thymoma with myasthenia gravis"@en ;
  schema:description "Thymoma is the slower-growing kind of thymic epithelial tumour, an indolent cancer of the thymus gland behind the breastbone that often announces itself through the autoimmune disease myasthenia gravis. Complete surgical removal cures most patients, radiotherapy is added when the tumour has grown through its capsule, and chemotherapy is used to shrink large tumours or control spread in the chest."@en ;
  schema:url <https://onco.cc/cancers/thymoma/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Thymoma> ;
  schema:citation <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1469>, <https://doi.org/10.1093/annonc/mdv277>, <https://en.wikipedia.org/wiki/Thymoma> ;
  onco:tag "subtype-page", "thoracic" ;
  onco:related <https://onco.cc/cancers/thymic-carcinoma/>, <https://onco.cc/cancers/thymic-epithelial/>, <https://onco.cc/cancers/lung-net/> ;
  onco:technologies <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/ct/>, <https://onco.cc/technologies/mri/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/octreotide-lanreotide/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/lenvatinib/> ;
  onco:terms <https://onco.cc/terms/irae/>, <https://onco.cc/terms/staging-systems/> ;
  onco:trials <https://onco.cc/trials/nct05683886/>, <https://onco.cc/trials/nct07598955/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-esmo-thymic-epithelial-tumours-guideline-ann-oncol-2015/>, <https://onco.cc/key-papers/paper-who-2021-thymus-mediastinum-classification-marx-jto-2022/>, <https://onco.cc/key-papers/paper-masaoka-thymoma-clinical-staging-cancer-1981/> ;
  onco:pipeline <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/trials/nct05683886/>, <https://onco.cc/trials/nct07598955/>, <https://onco.cc/drugs/kc1036/>, <https://onco.cc/drugs/eb-car30-nk/> ;
  onco:standardOfCare <https://onco.cc/technologies/ct/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/octreotide-lanreotide/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/terms/irae/>, <https://onco.cc/trials/nct05683886/>, <https://onco.cc/trials/nct07598955/> .